aluates Reports

$ 0.0

Automative

Global Radiopharmaceutical Market Research Report 2026

Published Date: 2026-01-16

Report Code: QYRE-Auto-26A42

Global Radiopharmaceutical Market Insights and Forecast to 2028

BUY CHAPTERS

Global Radiopharmaceutical Market Research Report 2026

Code: QYRE-Auto-26A42

Report

2026-01-16

Pages:128

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bracco Imaging

Bayer

GE Healthcare

China Isotope & Radiation

Eli Lilly

Siemens

Siemens AG

Dongcheng

Cardinal Health

Novartis

Curium Pharma

Aurobindo Pharma

China Isotope & Radiation

Lantheus Medical Imaging

Radiopharmaceutical Market Size

The global Radiopharmaceutical market was valued at US$ 11150 million in 2025 and is anticipated to reach US$ 20510 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

Radiopharmaceutical Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Radiopharmaceutical competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.In 2024, global Radiopharmaceuticals production reached approximately 139.47 m units, with an average global market price of around US$ 68.49 perunit.The average gross profit margin of this product is 72%.

The radiopharmaceutical market is driven primarily by the growing prevalence of cancer and cardiovascular diseases, which require precise diagnostic tools for early detection and treatment. The increasing adoption of nuclear medicine imaging techniques, such as PET and SPECT scans, has further fueled demand for radiopharmaceuticals. Additionally, technological advancements in radiopharmaceuticals, along with the development of new radioisotopes for more targeted therapies, are expanding the applications of these drugs, making them critical in personalized medicine.

Despite the promising growth, the radiopharmaceutical market faces significant challenges, including the high cost of production and the short half-life of many radioisotopes, which complicates distribution and storage. Regulatory hurdles are another barrier, as radiopharmaceuticals require stringent approval processes due to their radioactive nature. Moreover, limited availability of specialized infrastructure and the shortage of trained professionals in nuclear medicine also hinder widespread adoption, especially in developing regions.

There is widespread awareness of the use of radiation and radioisotopes in medicine, particularly for diagnosis (identification) and therapy (treatment) of various medical conditions. In developed countries (a quarter of the world population) about one person in 50 uses diagnostic nuclear medicine each year, and the frequency of therapy with radioisotopes is about one-tenth of this.

Nuclear medicine uses radiation to provide information about the functioning of a person's specific organs, or to treat disease. In most cases, the information is used by physicians to make a quick diagnosis of the patient's illness. The thyroid, bones, heart, liver, and many other organs can be easily imaged, and disorders in their function revealed. In some cases radiation can be used to treat diseased organs, or tumours.

Over 10,000 hospitals worldwide use radioisotopes in medicine, and about 90% of the procedures are for diagnosis. The most common radioisotope used in diagnosis is technetium-99 (Tc-99m) accounting for about 80% of all nuclear medicine procedures and 85% of diagnostic scans in nuclear medicine worldwide.Over 50 million nuclear medicine procedures are performed each year, and demand for radioisotopes is increasing.

This report delivers a comprehensive overview of the global Radiopharmaceutical market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Radiopharmaceutical. The Radiopharmaceutical market size, estimates, and forecasts are provided in terms of sales volume (K Dose) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Radiopharmaceutical market comprehensively. Regional market sizes by Type, by Application, by Nuclide, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Radiopharmaceutical manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Radiopharmaceutical Market Report

Report Metric	Details
Report Name	Radiopharmaceutical Market
Accounted market size in 2025	US$ 11150 million
Forecasted market size in 2032	US$ 20510 million
CAGR	9.2%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Diagnostic Radiopharmaceuticals Therapeutic Radiopharmaceuticals
Segment by Nuclide	Technetium-99m Fluorine-18 Iodine-123 Iodine-131 Radium-223 Iodine-125 Other
Segment by Therapeutic Areas	Oncology Cardiology Other
by Application	Hospital Inmaging Center Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Dongcheng, Seed Medical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Nuclide, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Radiopharmaceutical manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Radiopharmaceutical sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Radiopharmaceutical Market growing?

Ans: The Radiopharmaceutical Market witnessing a CAGR of 9.2% during the forecast period 2026-2032.

What is the Radiopharmaceutical Market size in 2032?

Ans: The Radiopharmaceutical Market size in 2032 will be US$ 20510 million.

Who are the main players in the Radiopharmaceutical Market report?

Ans: The main players in the Radiopharmaceutical Market are Cardinal Health, GE Healthcare, Lantheus Medical Imaging, Bayer, Eli Lilly, Bracco Imaging, Curium Pharma, Jubilant Pharmova, Aurobindo Pharma, Novartis, Siemens, NTP Radioisotopes, ANSTO, Polatom, China Isotope & Radiation, Dongcheng, Seed Medical

What are the Application segmentation covered in the Radiopharmaceutical Market report?

Ans: The Applications covered in the Radiopharmaceutical Market report are Hospital, Inmaging Center, Others

What are the Type segmentation covered in the Radiopharmaceutical Market report?

Ans: The Types covered in the Radiopharmaceutical Market report are Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals

1 Radiopharmaceutical Market Overview

1.1 Product Definition

1.2 Radiopharmaceutical by Type

1.2.1 Global Radiopharmaceutical Market Value by Type: 2025 vs 2032

1.2.2 Diagnostic Radiopharmaceuticals

1.2.3 Therapeutic Radiopharmaceuticals

1.3 Radiopharmaceutical by Nuclide

1.3.1 Global Radiopharmaceutical Market Value by Nuclide: 2025 vs 2032

1.3.2 Technetium-99m

1.3.3 Fluorine-18

1.3.4 Iodine-123

1.3.5 Iodine-131

1.3.6 Radium-223

1.3.7 Iodine-125

1.3.8 Other

1.4 Radiopharmaceutical by Therapeutic Areas

1.4.1 Global Radiopharmaceutical Market Value by Therapeutic Areas: 2025 vs 2032

1.4.2 Oncology

1.4.3 Cardiology

1.4.4 Other

1.5 Radiopharmaceutical by Application

1.5.1 Global Radiopharmaceutical Market Value by Application: 2025 vs 2032

1.5.2 Hospital

1.5.3 Inmaging Center

1.5.4 Others

1.6 Global Radiopharmaceutical Market Size Estimates and Forecasts

1.6.1 Global Radiopharmaceutical Revenue 2021–2032

1.6.2 Global Radiopharmaceutical Sales 2021–2032

1.6.3 Global Radiopharmaceutical Market Average Price (2021–2032)

1.7 Assumptions and Limitations

2 Radiopharmaceutical Market Competition by Manufacturers

2.1 Global Radiopharmaceutical Sales Market Share by Manufacturers (2021–2026)

2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Radiopharmaceutical Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Radiopharmaceutical, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Radiopharmaceutical, Product Types and Applications

2.7 Global Key Manufacturers of Radiopharmaceutical, Date of Entry into the Industry

2.8 Global Radiopharmaceutical Market Competitive Situation and Trends

2.8.1 Global Radiopharmaceutical Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Radiopharmaceutical Players Market Share by Revenue

2.8.3 Global Radiopharmaceutical Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Radiopharmaceutical Market Scenario by Region

3.1 Global Radiopharmaceutical Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Radiopharmaceutical Sales by Region: 2021–2032

3.2.1 Global Radiopharmaceutical Sales by Region: 2021–2026

3.2.2 Global Radiopharmaceutical Sales by Region: 2027–2032

3.3 Global Radiopharmaceutical Revenue by Region: 2021–2032

3.3.1 Global Radiopharmaceutical Revenue by Region: 2021–2026

3.3.2 Global Radiopharmaceutical Revenue by Region: 2027–2032

3.4 North America Radiopharmaceutical Market Facts & Figures by Country

3.4.1 North America Radiopharmaceutical Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Radiopharmaceutical Sales by Country (2021–2032)

3.4.3 North America Radiopharmaceutical Revenue by Country (2021–2032)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Radiopharmaceutical Market Facts & Figures by Country

3.5.1 Europe Radiopharmaceutical Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Radiopharmaceutical Sales by Country (2021–2032)

3.5.3 Europe Radiopharmaceutical Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Radiopharmaceutical Market Facts & Figures by Region

3.6.1 Asia Pacific Radiopharmaceutical Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Radiopharmaceutical Sales by Region (2021–2032)

3.6.3 Asia Pacific Radiopharmaceutical Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Radiopharmaceutical Market Facts & Figures by Country

3.7.1 Latin America Radiopharmaceutical Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Radiopharmaceutical Sales by Country (2021–2032)

3.7.3 Latin America Radiopharmaceutical Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Radiopharmaceutical Market Facts & Figures by Country

3.8.1 Middle East and Africa Radiopharmaceutical Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Radiopharmaceutical Sales by Country (2021–2032)

3.8.3 Middle East and Africa Radiopharmaceutical Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Radiopharmaceutical Sales by Type (2021–2032)

4.1.1 Global Radiopharmaceutical Sales by Type (2021–2026)

4.1.2 Global Radiopharmaceutical Sales by Type (2027–2032)

4.1.3 Global Radiopharmaceutical Sales Market Share by Type (2021–2032)

4.2 Global Radiopharmaceutical Revenue by Type (2021–2032)

4.2.1 Global Radiopharmaceutical Revenue by Type (2021–2026)

4.2.2 Global Radiopharmaceutical Revenue by Type (2027–2032)

4.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2021–2032)

4.3 Global Radiopharmaceutical Price by Type (2021–2032)

5 Segment by Application

5.1 Global Radiopharmaceutical Sales by Application (2021–2032)

5.1.1 Global Radiopharmaceutical Sales by Application (2021–2026)

5.1.2 Global Radiopharmaceutical Sales by Application (2027–2032)

5.1.3 Global Radiopharmaceutical Sales Market Share by Application (2021–2032)

5.2 Global Radiopharmaceutical Revenue by Application (2021–2032)

5.2.1 Global Radiopharmaceutical Revenue by Application (2021–2026)

5.2.2 Global Radiopharmaceutical Revenue by Application (2027–2032)

5.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2021–2032)

5.3 Global Radiopharmaceutical Price by Application (2021–2032)

6 Key Companies Profiled

6.1 Cardinal Health

6.1.1 Cardinal Health Company Information

6.1.2 Cardinal Health Description and Business Overview

6.1.3 Cardinal Health Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Cardinal Health Radiopharmaceutical Product Portfolio

6.1.5 Cardinal Health Recent Developments/Updates

6.2 GE Healthcare

6.2.1 GE Healthcare Company Information

6.2.2 GE Healthcare Description and Business Overview

6.2.3 GE Healthcare Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 GE Healthcare Radiopharmaceutical Product Portfolio

6.2.5 GE Healthcare Recent Developments/Updates

6.3 Lantheus Medical Imaging

6.3.1 Lantheus Medical Imaging Company Information

6.3.2 Lantheus Medical Imaging Description and Business Overview

6.3.3 Lantheus Medical Imaging Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Lantheus Medical Imaging Radiopharmaceutical Product Portfolio

6.3.5 Lantheus Medical Imaging Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Company Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Bayer Radiopharmaceutical Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 Eli Lilly

6.5.1 Eli Lilly Company Information

6.5.2 Eli Lilly Description and Business Overview

6.5.3 Eli Lilly Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 Eli Lilly Radiopharmaceutical Product Portfolio

6.5.5 Eli Lilly Recent Developments/Updates

6.6 Bracco Imaging

6.6.1 Bracco Imaging Company Information

6.6.2 Bracco Imaging Description and Business Overview

6.6.3 Bracco Imaging Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Bracco Imaging Radiopharmaceutical Product Portfolio

6.6.5 Bracco Imaging Recent Developments/Updates

6.7 Curium Pharma

6.7.1 Curium Pharma Company Information

6.7.2 Curium Pharma Description and Business Overview

6.7.3 Curium Pharma Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Curium Pharma Radiopharmaceutical Product Portfolio

6.7.5 Curium Pharma Recent Developments/Updates

6.8 Jubilant Pharmova

6.8.1 Jubilant Pharmova Company Information

6.8.2 Jubilant Pharmova Description and Business Overview

6.8.3 Jubilant Pharmova Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Jubilant Pharmova Radiopharmaceutical Product Portfolio

6.8.5 Jubilant Pharmova Recent Developments/Updates

6.9 Aurobindo Pharma

6.9.1 Aurobindo Pharma Company Information

6.9.2 Aurobindo Pharma Description and Business Overview

6.9.3 Aurobindo Pharma Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.9.4 Aurobindo Pharma Radiopharmaceutical Product Portfolio

6.9.5 Aurobindo Pharma Recent Developments/Updates

6.10 Novartis

6.10.1 Novartis Company Information

6.10.2 Novartis Description and Business Overview

6.10.3 Novartis Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.10.4 Novartis Radiopharmaceutical Product Portfolio

6.10.5 Novartis Recent Developments/Updates

6.11 Siemens

6.11.1 Siemens Company Information

6.11.2 Siemens Description and Business Overview

6.11.3 Siemens Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.11.4 Siemens Radiopharmaceutical Product Portfolio

6.11.5 Siemens Recent Developments/Updates

6.12 NTP Radioisotopes

6.12.1 NTP Radioisotopes Company Information

6.12.2 NTP Radioisotopes Description and Business Overview

6.12.3 NTP Radioisotopes Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.12.4 NTP Radioisotopes Radiopharmaceutical Product Portfolio

6.12.5 NTP Radioisotopes Recent Developments/Updates

6.13 ANSTO

6.13.1 ANSTO Company Information

6.13.2 ANSTO Description and Business Overview

6.13.3 ANSTO Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.13.4 ANSTO Radiopharmaceutical Product Portfolio

6.13.5 ANSTO Recent Developments/Updates

6.14 Polatom

6.14.1 Polatom Company Information

6.14.2 Polatom Description and Business Overview

6.14.3 Polatom Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.14.4 Polatom Radiopharmaceutical Product Portfolio

6.14.5 Polatom Recent Developments/Updates

6.15 China Isotope & Radiation

6.15.1 China Isotope & Radiation Company Information

6.15.2 China Isotope & Radiation Description and Business Overview

6.15.3 China Isotope & Radiation Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.15.4 China Isotope & Radiation Radiopharmaceutical Product Portfolio

6.15.5 China Isotope & Radiation Recent Developments/Updates

6.16 Dongcheng

6.16.1 Dongcheng Company Information

6.16.2 Dongcheng Description and Business Overview

6.16.3 Dongcheng Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.16.4 Dongcheng Radiopharmaceutical Product Portfolio

6.16.5 Dongcheng Recent Developments/Updates

6.17 Seed Medical

6.17.1 Seed Medical Company Information

6.17.2 Seed Medical Description and Business Overview

6.17.3 Seed Medical Radiopharmaceutical Sales, Revenue, and Gross Margin (2021–2026)

6.17.4 Seed Medical Radiopharmaceutical Product Portfolio

6.17.5 Seed Medical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Radiopharmaceutical Industry Chain Analysis

7.2 Radiopharmaceutical Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Radiopharmaceutical Production Mode & Process Analysis

7.4 Radiopharmaceutical Sales and Marketing

7.4.1 Radiopharmaceutical Sales Channels

7.4.2 Radiopharmaceutical Distributors

7.5 Radiopharmaceutical Customer Analysis

8 Radiopharmaceutical Market Dynamics

8.1 Radiopharmaceutical Industry Trends

8.2 Radiopharmaceutical Market Drivers

8.3 Radiopharmaceutical Market Challenges

8.4 Radiopharmaceutical Market Restraints

8.5 Impact of U.S. Tariffs

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bracco Imaging

Bayer

GE Healthcare

China Isotope & Radiation

Eli Lilly

Siemens

Siemens AG

Dongcheng

Cardinal Health

Novartis

Curium Pharma

Aurobindo Pharma

China Isotope & Radiation

Lantheus Medical Imaging

List of Tables

Table 1. Global Radiopharmaceutical Market Value by Type (US$ Million), 2025 vs 2032

Table 2. Global Radiopharmaceutical Market Value by Nuclide (US$ Million), 2025 vs 2032

Table 3. Global Radiopharmaceutical Market Value by Therapeutic Areas (US$ Million), 2025 vs 2032

Table 4. Global Radiopharmaceutical Market Value by Application (US$ Million), 2025 vs 2032

Table 5. Global Radiopharmaceutical Market Competitive Situation by Manufacturers in 2025

Table 6. Global Radiopharmaceutical Sales (K Dose) of Key Manufacturers (2021–2026)

Table 7. Global Radiopharmaceutical Sales Market Share by Manufacturers (2021–2026)

Table 8. Global Radiopharmaceutical Revenue (US$ Million) by Manufacturers (2021–2026)

Table 9. Global Radiopharmaceutical Revenue Share by Manufacturers (2021–2026)

Table 10. Global Market Radiopharmaceutical Average Price (USD/Dose) of Key Manufacturers (2021–2026)

Table 11. Global Key Players of Radiopharmaceutical, Industry Ranking, 2023 vs 2024 vs 2025

Table 12. Global Key Manufacturers of Radiopharmaceutical, Manufacturing Sites and Headquarters

Table 13. Global Key Manufacturers of Radiopharmaceutical, Product Types and Applications

Table 14. Global Key Manufacturers of Radiopharmaceutical, Date of Entry into the Industry

Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 16. Global Radiopharmaceutical Companies by Tier (Tier 1, Tier 2, Tier 3), based on Radiopharmaceutical Revenue, 2025

Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 18. Global Radiopharmaceutical Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 19. Global Radiopharmaceutical Sales by Region (K Dose), 2021–2026

Table 20. Global Radiopharmaceutical Sales Market Share by Region (2021–2026)

Table 21. Global Radiopharmaceutical Sales by Region (K Dose), 2027–2032

Table 22. Global Radiopharmaceutical Sales Market Share by Region (2027–2032)

Table 23. Global Radiopharmaceutical Revenue by Region (US$ Million), 2021–2026

Table 24. Global Radiopharmaceutical Revenue Market Share by Region (2021–2026)

Table 25. Global Radiopharmaceutical Revenue by Region (US$ Million), 2027–2032

Table 26. Global Radiopharmaceutical Revenue Market Share by Region (2027–2032)

Table 27. North America Radiopharmaceutical Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 28. North America Radiopharmaceutical Sales by Country (K Dose), 2021–2026

Table 29. North America Radiopharmaceutical Sales by Country (K Dose), 2027–2032

Table 30. North America Radiopharmaceutical Revenue by Country (US$ Million), 2021–2026

Table 31. North America Radiopharmaceutical Revenue by Country (US$ Million), 2027–2032

Table 32. Europe Radiopharmaceutical Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 33. Europe Radiopharmaceutical Sales by Country (K Dose), 2021–2026

Table 34. Europe Radiopharmaceutical Sales by Country (K Dose), 2027–2032

Table 35. Europe Radiopharmaceutical Revenue by Country (US$ Million), 2021–2026

Table 36. Europe Radiopharmaceutical Revenue by Country (US$ Million), 2027–2032

Table 37. Asia Pacific Radiopharmaceutical Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

Table 38. Asia Pacific Radiopharmaceutical Sales by Region (K Dose), 2021–2026

Table 39. Asia Pacific Radiopharmaceutical Sales by Region (K Dose), 2027–2032

Table 40. Asia Pacific Radiopharmaceutical Revenue by Region (US$ Million), 2021–2026

Table 41. Asia Pacific Radiopharmaceutical Revenue by Region (US$ Million), 2027–2032

Table 42. Latin America Radiopharmaceutical Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 43. Latin America Radiopharmaceutical Sales by Country (K Dose), 2021–2026

Table 44. Latin America Radiopharmaceutical Sales by Country (K Dose), 2027–2032

Table 45. Latin America Radiopharmaceutical Revenue by Country (US$ Million), 2021–2026

Table 46. Latin America Radiopharmaceutical Revenue by Country (US$ Million), 2027–2032

Table 47. Middle East and Africa Radiopharmaceutical Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

Table 48. Middle East and Africa Radiopharmaceutical Sales by Country (K Dose), 2021–2026

Table 49. Middle East and Africa Radiopharmaceutical Sales by Country (K Dose), 2027–2032

Table 50. Middle East and Africa Radiopharmaceutical Revenue by Country (US$ Million), 2021–2026

Table 51. Middle East and Africa Radiopharmaceutical Revenue by Country (US$ Million), 2027–2032

Table 52. Global Radiopharmaceutical Sales (K Dose) by Type (2021–2026)

Table 53. Global Radiopharmaceutical Sales (K Dose) by Type (2027–2032)

Table 54. Global Radiopharmaceutical Sales Market Share by Type (2021–2026)

Table 55. Global Radiopharmaceutical Sales Market Share by Type (2027–2032)

Table 56. Global Radiopharmaceutical Revenue (US$ Million) by Type (2021–2026)

Table 57. Global Radiopharmaceutical Revenue (US$ Million) by Type (2027–2032)

Table 58. Global Radiopharmaceutical Revenue Market Share by Type (2021–2026)

Table 59. Global Radiopharmaceutical Revenue Market Share by Type (2027–2032)

Table 60. Global Radiopharmaceutical Price (USD/Dose) by Type (2021–2026)

Table 61. Global Radiopharmaceutical Price (USD/Dose) by Type (2027–2032)

Table 62. Global Radiopharmaceutical Sales (K Dose) by Application (2021–2026)

Table 63. Global Radiopharmaceutical Sales (K Dose) by Application (2027–2032)

Table 64. Global Radiopharmaceutical Sales Market Share by Application (2021–2026)

Table 65. Global Radiopharmaceutical Sales Market Share by Application (2027–2032)

Table 66. Global Radiopharmaceutical Revenue (US$ Million) by Application (2021–2026)

Table 67. Global Radiopharmaceutical Revenue (US$ Million) by Application (2027–2032)

Table 68. Global Radiopharmaceutical Revenue Market Share by Application (2021–2026)

Table 69. Global Radiopharmaceutical Revenue Market Share by Application (2027–2032)

Table 70. Global Radiopharmaceutical Price (USD/Dose) by Application (2021–2026)

Table 71. Global Radiopharmaceutical Price (USD/Dose) by Application (2027–2032)

Table 72. Cardinal Health Company Information

Table 73. Cardinal Health Description and Business Overview

Table 74. Cardinal Health Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 75. Cardinal Health Radiopharmaceutical Product

Table 76. Cardinal Health Recent Developments/Updates

Table 77. GE Healthcare Company Information

Table 78. GE Healthcare Description and Business Overview

Table 79. GE Healthcare Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 80. GE Healthcare Radiopharmaceutical Product

Table 81. GE Healthcare Recent Developments/Updates

Table 82. Lantheus Medical Imaging Company Information

Table 83. Lantheus Medical Imaging Description and Business Overview

Table 84. Lantheus Medical Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 85. Lantheus Medical Imaging Radiopharmaceutical Product

Table 86. Lantheus Medical Imaging Recent Developments/Updates

Table 87. Bayer Company Information

Table 88. Bayer Description and Business Overview

Table 89. Bayer Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 90. Bayer Radiopharmaceutical Product

Table 91. Bayer Recent Developments/Updates

Table 92. Eli Lilly Company Information

Table 93. Eli Lilly Description and Business Overview

Table 94. Eli Lilly Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 95. Eli Lilly Radiopharmaceutical Product

Table 96. Eli Lilly Recent Developments/Updates

Table 97. Bracco Imaging Company Information

Table 98. Bracco Imaging Description and Business Overview

Table 99. Bracco Imaging Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 100. Bracco Imaging Radiopharmaceutical Product

Table 101. Bracco Imaging Recent Developments/Updates

Table 102. Curium Pharma Company Information

Table 103. Curium Pharma Description and Business Overview

Table 104. Curium Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 105. Curium Pharma Radiopharmaceutical Product

Table 106. Curium Pharma Recent Developments/Updates

Table 107. Jubilant Pharmova Company Information

Table 108. Jubilant Pharmova Description and Business Overview

Table 109. Jubilant Pharmova Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 110. Jubilant Pharmova Radiopharmaceutical Product

Table 111. Jubilant Pharmova Recent Developments/Updates

Table 112. Aurobindo Pharma Company Information

Table 113. Aurobindo Pharma Description and Business Overview

Table 114. Aurobindo Pharma Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 115. Aurobindo Pharma Radiopharmaceutical Product

Table 116. Aurobindo Pharma Recent Developments/Updates

Table 117. Novartis Company Information

Table 118. Novartis Description and Business Overview

Table 119. Novartis Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 120. Novartis Radiopharmaceutical Product

Table 121. Novartis Recent Developments/Updates

Table 122. Siemens Company Information

Table 123. Siemens Description and Business Overview

Table 124. Siemens Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 125. Siemens Radiopharmaceutical Product

Table 126. Siemens Recent Developments/Updates

Table 127. NTP Radioisotopes Company Information

Table 128. NTP Radioisotopes Description and Business Overview

Table 129. NTP Radioisotopes Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 130. NTP Radioisotopes Radiopharmaceutical Product

Table 131. NTP Radioisotopes Recent Developments/Updates

Table 132. ANSTO Company Information

Table 133. ANSTO Description and Business Overview

Table 134. ANSTO Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 135. ANSTO Radiopharmaceutical Product

Table 136. ANSTO Recent Developments/Updates

Table 137. Polatom Company Information

Table 138. Polatom Description and Business Overview

Table 139. Polatom Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 140. Polatom Radiopharmaceutical Product

Table 141. Polatom Recent Developments/Updates

Table 142. China Isotope & Radiation Company Information

Table 143. China Isotope & Radiation Description and Business Overview

Table 144. China Isotope & Radiation Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 145. China Isotope & Radiation Radiopharmaceutical Product

Table 146. China Isotope & Radiation Recent Developments/Updates

Table 147. Dongcheng Company Information

Table 148. Dongcheng Description and Business Overview

Table 149. Dongcheng Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 150. Dongcheng Radiopharmaceutical Product

Table 151. Dongcheng Recent Developments/Updates

Table 152. Seed Medical Company Information

Table 153. Seed Medical Description and Business Overview

Table 154. Seed Medical Radiopharmaceutical Sales (K Dose), Revenue (US$ Million), Price (USD/Dose), and Gross Margin (2021–2026)

Table 155. Seed Medical Radiopharmaceutical Product

Table 156. Seed Medical Recent Developments/Updates

Table 157. Key Raw Materials Lists

Table 158. Raw Materials Key Suppliers Lists

Table 159. Radiopharmaceutical Distributors List

Table 160. Radiopharmaceutical Customers List

Table 161. Radiopharmaceutical Market Trends

Table 162. Radiopharmaceutical Market Drivers

Table 163. Radiopharmaceutical Market Challenges

Table 164. Radiopharmaceutical Market Restraints

Table 165. Research Programs/Design for This Report

Table 166. Key Data Information from Secondary Sources

Table 167. Key Data Information from Primary Sources

Table 168. Authors List of This Report

List of Figures

Figure 1. Product Picture of Radiopharmaceutical

Figure 2. Global Radiopharmaceutical Market Value by Type (US$ Million), 2021–2032

Figure 3. Global Radiopharmaceutical Market Share by Type: 2025 & 2032

Figure 4. Diagnostic Radiopharmaceuticals Product Picture

Figure 5. Therapeutic Radiopharmaceuticals Product Picture

Figure 6. Global Radiopharmaceutical Market Value by Nuclide (US$ Million), 2021–2032

Figure 7. Global Radiopharmaceutical Market Share by Nuclide: 2025 vs 2032

Figure 8. Technetium-99m Product Picture

Figure 9. Fluorine-18 Product Picture

Figure 10. Iodine-123 Product Picture

Figure 11. Iodine-131 Product Picture

Figure 12. Radium-223 Product Picture

Figure 13. Iodine-125 Product Picture

Figure 14. Other Product Picture

Figure 15. Global Radiopharmaceutical Market Value by Therapeutic Areas (US$ Million), 2021–2032

Figure 16. Global Radiopharmaceutical Market Share by Therapeutic Areas: 2025 vs 2032

Figure 17. Oncology Product Picture

Figure 18. Cardiology Product Picture

Figure 19. Other Product Picture

Figure 20. Global Radiopharmaceutical Market Value by Application (US$ Million), 2021–2032

Figure 21. Global Radiopharmaceutical Market Share by Application: 2025 & 2032

Figure 22. Hospital

Figure 23. Inmaging Center

Figure 24. Others

Figure 25. Global Radiopharmaceutical Revenue, (US$ Million), 2021 vs 2025 vs 2032

Figure 26. Global Radiopharmaceutical Market Size (US$ Million), 2021–2032

Figure 27. Global Radiopharmaceutical Sales (K Dose), 2021–2032

Figure 28. Global Radiopharmaceutical Average Price (USD/Dose), 2021–2032

Figure 29. Radiopharmaceutical Report Years Considered

Figure 30. Radiopharmaceutical Sales Share by Manufacturers in 2025

Figure 31. Global Radiopharmaceutical Revenue Share by Manufacturers in 2025

Figure 32. Top 5 and Top 10 Global Radiopharmaceutical Players: Market Share by Revenue in Radiopharmaceutical in 2025

Figure 33. Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 34. Global Radiopharmaceutical Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Figure 35. North America Radiopharmaceutical Sales Market Share by Country (2021–2032)

Figure 36. North America Radiopharmaceutical Revenue Market Share by Country (2021–2032)

Figure 37. U.S. Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 38. Canada Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 39. Europe Radiopharmaceutical Sales Market Share by Country (2021–2032)

Figure 40. Europe Radiopharmaceutical Revenue Market Share by Country (2021–2032)

Figure 41. Germany Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 42. France Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 43. U.K. Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 44. Italy Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 45. Russia Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 46. Asia Pacific Radiopharmaceutical Sales Market Share by Region (2021–2032)

Figure 47. Asia Pacific Radiopharmaceutical Revenue Market Share by Region (2021–2032)

Figure 48. China Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 49. Japan Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 50. South Korea Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 51. India Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 52. Australia Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 53. China Taiwan Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 54. Indonesia Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 55. Thailand Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 56. Malaysia Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 57. Philippines Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 58. Latin America Radiopharmaceutical Sales Market Share by Country (2021–2032)

Figure 59. Latin America Radiopharmaceutical Revenue Market Share by Country (2021–2032)

Figure 60. Mexico Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 61. Brazil Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 62. Argentina Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 63. Middle East and Africa Radiopharmaceutical Sales Market Share by Country (2021–2032)

Figure 64. Middle East and Africa Radiopharmaceutical Revenue Market Share by Country (2021–2032)

Figure 65. Turkey Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 66. Saudi Arabia Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 67. U.A.E Radiopharmaceutical Revenue Growth Rate (US$ Million), 2021–2032

Figure 68. Global Sales Market Share of Radiopharmaceutical by Type (2021–2032)

Figure 69. Global Revenue Market Share of Radiopharmaceutical by Type (2021–2032)

Figure 70. Global Radiopharmaceutical Price (USD/Dose) by Type (2021–2032)

Figure 71. Global Sales Market Share of Radiopharmaceutical by Application (2021–2032)

Figure 72. Global Revenue Market Share of Radiopharmaceutical by Application (2021–2032)

Figure 73. Global Radiopharmaceutical Price (USD/Dose) by Application (2021–2032)

Figure 74. Radiopharmaceutical Value Chain

Figure 75. Channels of Distribution (Direct Vs Distribution)

Figure 76. Bottom-up and Top-down Approaches for This Report

Figure 77. Data Triangulation

Figure 78. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global SPECT and PET Radiopharmaceuticals Market Research Report 2024

Global Nuclear Medicine Market Research Report 2025

Global Radiopharmaceuticals in Nuclear Medicine Market Research Report 2025

Global Radiopharmaceutical Therapy Market Research Report 2025

Global Diagnostic Radiopharmaceuticals Market Research Report 2024

Global SPECT Radiopharmaceuticals Market Research Report 2025

Global Diagnostic Nuclear Medicines Market Insights Forecast to 2030

Global Radiopharmaceuticals for Diagnosis Market Research Report 2024

Global Diagnostic Radioisotopes Market Insights Forecast to 2030

Global Targeted Radiopharmaceuticals Market Research Report 2024

Global Radiopharmaceutical Injector Market Research Report 2025

Global PET Radioisotope Radiopharmaceuticals in PET Imaging Market Research Report 2024

Global Therapeutic Radiopharmaceuticals Market Insights Forecast to 2030

Radiopharmaceutical Theranostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Radioactive Therapeutic Drugs Market Research Report 2024

Global Therapeutic Radioisotopes Market Insights Forecast to 2030

Global Nuclear Radiopharmaceutical Market Insights Forecast to 2030

Global Radioisotopes in Medicine Market Research Report 2025

Global Medical Radioisotopes Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions